Home › Foundation Medicine to Profile Samples for European Cancer Network to Aid Clinical Trial Enrollment

Foundation Medicine to Profile Samples for European Cancer Network to Aid Clinical Trial Enrollment

Jan 30, 2018

NEW YORK (GenomeWeb) – Foundation Medicine said today that it is collaborating with the European Organisation for Research and Treatment of Cancer (EORTC) to provide cancer genomic profiling tests to help determine eligibility of patients for clinical trials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

  2. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  3. FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

  4. Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

  5. Abbott Q3 Dx Business Grows 43 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.